Exocyclic DNA adducts as secondary markers for oxidative stress: applications in human cancer etiology and risk assessment.
Bartsch
H
H
German Cancer Research Center (DKFZ), Division of Toxicology and Cancer Risk Factors, Heidelberg.
Nair
J
J
D000818:Animals; D002273:Carcinogens / Q000494:pharmacology; D018736:DNA Adducts; D004249:DNA Damage; D004273:DNA, Neoplasm; D003839:Deoxyadenosines / Q000032:analysis; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000032:analysis; D003849:Deoxyguanosine / Q000031:analogs & derivatives* / Q000032:analysis; D005819:Genetic Markers; D006801:Humans; D009369:Neoplasms / Q000209:etiology / Q000235:genetics* / Q000473:pathology; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000235:genetics*; D018570:Risk Assessment
D002273:Carcinogens; D018736:DNA Adducts; D004273:DNA, Neoplasm; D003839:Deoxyadenosines; D005819:Genetic Markers; D003841:Deoxycytidine; C079486:N(2),3-ethenodeoxyguanosine; C032221:1,N(6)-ethenodeoxyadenosine; C032222:3,N(4)-ethenodeoxycytidine; D003849:Deoxyguanosine